Clinical Trial Update: Meta-analysis - Eltrombopag

View source ↗

Summary

A meta-analysis update assessing the efficacy and safety of eltrombopag for thrombocytopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• Eltrombopag (Promacta, Revolade) (eltrombopag)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Thrombocytopaenia | Status: COMPLETED